{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T21:59:59Z","timestamp":1790114399160,"version":"4.0.1"},"reference-count":40,"publisher":"JMIR Publications Inc.","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JMIR Res Protoc"],"abstract":"Abstract<\/jats:title>\n \n Background<\/jats:title>\n About 828 million adults were estimated to be living with diabetes, and this is projected to affect 1 in 9 adults by 2045. In Belgium, 7.6% of adults have been diagnosed with the disease; however, approximately 1 in 3 people remain unaware of their condition. Advances in information and communication technology (ICT) have improved care quality and health management, and facilitated communication between health care providers and patients. The Digital Diabetes Patient Reminder (DIPAR) tool was developed as an extension of the existing patient portal to support diabetes management through automated reminders for overdue monitoring, and a consultation dashboard that facilitates communication between patients and health care providers. This pilot study was conducted within the European Joint Action on Cardiovascular Diseases and Diabetes framework.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n \n This trial aims to evaluate whether the implementation of the DIPAR tool improves adherence to recommended diabetes follow-up. The primary objective is to determine whether the intervention increases the proportion of adults with type 2 diabetes mellitus (T2DM) who receive at least one documented annual albuminuria measurement in the electronic medical records (EMR). The key secondary objective is to assess whether the intervention increases the proportion of patients with at least 2 documented hemoglobin A\n 1c<\/jats:sub>\n (HbA\n 1c<\/jats:sub>\n ) measurements within 12 months. Exploratory objectives include evaluating changes in diabetes-related clinical parameters (HbA\n 1c<\/jats:sub>\n , albuminuria, low-density lipoprotein (LDL)\u2013cholesterol, and systolic blood pressure), as well as the usability and acceptability of the intervention among patients and health care professionals.\n <\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n This multicenter, pragmatic, parallel-group, proof-of-concept randomized controlled trial (RCT) will recruit approximately 200 adults with T2DM receiving outpatient diabetes care at 2 hospitals in Flanders, Belgium. Participants will be randomized (1:1), stratified only by study center, to receive either the DIPAR tool extension in addition to usual care or usual care alone using the standard patient portal. The intervention consists of automated reminders for timely follow-up and a consultation dashboard to be used by patients and physicians. The intervention will last 12 months. Clinical outcomes will be extracted from the EMR, while usability and acceptability will be evaluated using the Dutch and English versions of the Mobile Health App Usability Questionnaire (MAUQ), semistructured interviews, and focus group discussions. The primary analysis will follow the intention-to-treat principle using regression-based methods appropriate for each outcome.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n Recruitment started in October 2025 and was completed in December 2025. A total of 201 patients were recruited, with 100 participants allocated to the intervention group. Data extraction did not commence until March 2026, after the completion of the statistical analysis plan and the protocol submission. Data analysis has not started.<\/jats:p>\n <\/jats:sec>\n \n Conclusions<\/jats:title>\n This study will provide insights into the potential added value of a digital reminder tool for T2DM management in a real-world setting as well as the usability and acceptability of this tool.<\/jats:p>\n <\/jats:sec>","DOI":"10.2196\/93006","type":"journal-article","created":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T21:00:57Z","timestamp":1790110857000},"page":"e93006-e93006","source":"Crossref","is-referenced-by-count":0,"title":["The Digital Diabetes Patient Reminder Tool for Adults With Type 2 Diabetes: Protocol for a Proof-of-Concept Randomized Controlled Trial"],"prefix":"10.2196","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-4455-2873","authenticated-orcid":false,"given":"Barbara","family":"Annancy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0744-3923","authenticated-orcid":false,"given":"Steve","family":"Van den Bulck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6875-8366","authenticated-orcid":false,"given":"Steffen","family":"Fieuws","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3427-6657","authenticated-orcid":false,"given":"Laura","family":"Van den Mooter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3523-669X","authenticated-orcid":false,"given":"Roman","family":"Vangoitsenhoven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5303-2290","authenticated-orcid":false,"given":"Geert","family":"Goderis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1010","published-online":{"date-parts":[[2026,9,22]]},"reference":[{"key":"R1","unstructured":"Diabetes. World Health Organization. URL: https:\/\/www.who.int\/health-topics\/diabetes#tab=tab_1 [Accessed 26-01-2024]"},{"key":"R2","unstructured":"Type 2 diabetes. CDC. 2024. URL: https:\/\/www.cdc.gov\/diabetes\/basics\/type2.html [Accessed 01-03-2024]"},{"issue":"6","key":"R3","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1177\/2040622314548679","article-title":"Early onset type 2 diabetes: risk factors, clinical impact and management","volume":"5","author":"Wilmot","journal-title":"Ther Adv Chronic Dis"},{"issue":"5","key":"R4","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.2337\/dc06-1813","article-title":"Rising incidence of type 2 diabetes in children in the U.K","volume":"30","author":"Haines","journal-title":"Diabetes Care"},{"issue":"3","key":"R5","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/S1056-8727(01)00212-4","article-title":"Diabetes and macrovascular disease","volume":"16","author":"Vinik","journal-title":"J Diabetes Complicat"},{"issue":"12","key":"R6","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1007\/s00125-022-05787-2","article-title":"Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)","volume":"65","author":"Davies","journal-title":"Diabetologia"},{"issue":"10397","key":"R7","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S0140-6736(23)01301-6","article-title":"Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021","volume":"402","author":"Ong","journal-title":"The Lancet"},{"key":"R8","unstructured":"Global diabetes cases to soar from 529 million to 1.3 billion by 2050. Institute for Health Metrics and Evaluation. URL: https:\/\/www.healthdata.org\/news-events\/newsroom\/news-releases\/global-diabetes-cases-soar-529-million-13-billion-2050 [Accessed 04-03-2024]"},{"key":"R9","unstructured":"Diabetes. Gezondbelgie.be. URL: https:\/\/www.gezondbelgie.be\/nl\/gezondheidstoestand\/niet-overdraagbare-aandoeningen\/diabetes [Accessed 04-03-2026]"},{"issue":"3","key":"R10","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.ecl.2021.05.013","article-title":"An update on the epidemiology of type 2 diabetes: a global perspective","volume":"50","author":"Tinajero","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"6","key":"R11","doi-asserted-by":"publisher","first-page":"291","DOI":"10.3345\/cep.2020.01333","article-title":"Recent trends of healthcare information and communication technologies in pediatrics: a systematic review","volume":"65","author":"Jung","journal-title":"Clin Exp Pediatr"},{"issue":"16","key":"R12","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2022.869793","article-title":"Efficacy and pitfalls of digital technologies in healthcare services: a systematic review of two decades","volume":"10","author":"Akhtar","journal-title":"Front Public Health"},{"issue":"9","key":"R13","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.3390\/healthcare9091192","article-title":"E-health practices and technologies: a systematic review from 2014 to 2019","volume":"9","author":"da Fonseca","journal-title":"Health Care (Don Mills)"},{"issue":"2","key":"R14","doi-asserted-by":"publisher","DOI":"10.2196\/16266","article-title":"Effect of a mobile phone-based glucose-monitoring and feedback system for type 2 diabetes management in multiple primary care clinic settings: cluster randomized controlled trial","volume":"8","author":"Yang","journal-title":"JMIR Mhealth Uhealth"},{"issue":"6","key":"R15","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1177\/1357633X16657500","article-title":"An internet-based health gateway device for interactive communication and automatic data uploading: clinical efficacy for type 2 diabetes in a multi-centre trial","volume":"23","author":"Cho","journal-title":"J Telemed Telecare"},{"issue":"1","key":"R16","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-59588-x","article-title":"A cluster-randomized trial of the effectiveness of a triple-faceted intervention promoting adherence to primary care physician visits by diabetes patients","volume":"10","author":"Noda","journal-title":"Sci Rep"},{"issue":"9","key":"R17","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1111\/jdi.14227","article-title":"Internet of things\u2010based approach for glycemic control in people with type 2 diabetes: a randomized controlled trial","volume":"15","author":"Bouchi","journal-title":"J of Diabetes Invest"},{"key":"R18","doi-asserted-by":"publisher","DOI":"10.2196\/53054","article-title":"Effectiveness of a smartphone app to promote physical activity among persons with type 2 diabetes: randomized controlled trial","volume":"13","author":"Bonn","journal-title":"Interact J Med Res"},{"issue":"4","key":"R19","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1089\/tmj.2022.0028","article-title":"Telemedicine as a motivational tool to optimize metabolic control in patients with diabetes in Turkey: a prospective, randomized, controlled TeleDiab trial","volume":"29","author":"Calikoglu","journal-title":"Telemed J E Health"},{"issue":"34","key":"R20","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2018.33.e213","article-title":"Real-world evidence versus randomized controlled trial: clinical research based on electronic medical records","volume":"33","author":"Kim","journal-title":"J Korean Med Sci"},{"issue":"2","key":"R21","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s10488-010-0319-7","article-title":"Outcomes for implementation research: conceptual distinctions, measurement challenges, and research agenda","volume":"38","author":"Proctor","journal-title":"Adm Policy Ment Health"},{"issue":"1","key":"R22","doi-asserted-by":"publisher","first-page":"4","DOI":"10.4415\/ANN_24_01_02","article-title":"Tackling the challenge of cardiovascular diseases and diabetes across Europe: a joint action by more than 300 public health professionals. Commentary","volume":"60","author":"Armocida","journal-title":"Ann Ist Super Sanita"},{"key":"R23","unstructured":"The digital diabetes patient reminder tool to improve clinical outcomes and process of management in adults with type 2 diabetes: a proof-of-concept randomized controlled trial \u2014 joint action for cardiovascular diseases and diabetes. Ku Leuven. URL: https:\/\/gbiomed.kuleuven.be\/english\/research\/50000687\/50000695\/NL\/jacardi-eng\/dipar-rct [Accessed 20-01-2026]"},{"key":"R24","unstructured":"Work package 10: patients\u2019 self-management \u2018be the master of your health\u2019. Jacardi. URL: https:\/\/jacardi.eu\/services\/patient-self-management\/ [Accessed 12-01-2026]"},{"issue":"4","key":"R25","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1161\/HYPERTENSIONAHA.121.17323","article-title":"Albuminuria testing in hypertension and diabetes: an individual-participant data meta-analysis in a global consortium","volume":"78","author":"Shin","journal-title":"Hypertension"},{"issue":"4","key":"R26","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1016\/j.mayocp.2020.07.037","article-title":"Adherence to chronic kidney disease screening guidelines among patients with type 2 diabetes in a US administrative claims database","volume":"96","author":"Folkerts","journal-title":"Mayo Clin Proc"},{"key":"R27","doi-asserted-by":"publisher","DOI":"10.1177\/21501327211003683","article-title":"Optimal early diagnosis and monitoring of diabetic kidney disease in type 2 diabetes mellitus: addressing the barriers to albuminuria testing","volume":"12","author":"Christofides","journal-title":"J Prim Care Community Health"},{"key":"R28","doi-asserted-by":"crossref","unstructured":"Devos C Cordon A Lefevre M et al. Performance of the belgian health system: report 2019\u2014supplement: technical sheets for indicators. Belgian Health Care Knowledge Centre (KCE); 2019. URL: https:\/\/www.researchgate.net\/publication\/388372443_Performance_of_the_Belgian_health_system_Report_2019_-_Supplement_technical_sheets_for_indicators [Accessed 09-09-2026]","DOI":"10.57598\/R313S2"},{"key":"R29","unstructured":"Minimale follow-up van diabetes pati\u00ebnten niet behandeld met insuline - 2024 - gewesten. IMA atlas - atlas AIM. 2024. URL: https:\/\/atlas.ima-aim.be\/viewer?lang=nl [Accessed 09-01-2026]"},{"key":"R30","unstructured":"IMA atlas - atlas AIM | minimale follow-up van diabetes pati\u00ebnten behandeld met insuline - gewesten brussels hoofdstedelijk gewest, vlaams gewest, waals gewest, onbekend. URL: https:\/\/atlas.ima-aim.be\/mosaic\/nl-nl\/ima-atlas\/doelgroepenzorg\/diabetes [Accessed 09-07-2026]"},{"key":"R31","unstructured":"What is mynexuzhealth? | access to your digital health record. Nexuzhealth. URL: https:\/\/www.nexuzhealth.com\/en\/mynexuzhealth\/what-is-mynexuzhealth [Accessed 20-01-2026]"},{"key":"R32","unstructured":"Wegwijs in het e-health landschap! Vlaams Patienten. URL: https:\/\/vlaamspatientenplatform.be\/nl\/advies-en-tips\/wegwijs-in-het-e-health-landschap [Accessed 20-01-2026]"},{"key":"R33","unstructured":"Goossens M Kalyvas C Kennel T Casteren VV Doggen K . De zorgtrajecten diabetes mellitus type 2 en chronische nierinsuffici\u00ebntie en kwaliteit van zorg (EVACQ). Sciensano; 2019. [doi: 10.25608\/34ka-c432]"},{"key":"R34","volume":"387","author":"Casteren","journal-title":"Medi-Sfeer"},{"issue":"1","key":"R35","doi-asserted-by":"publisher","DOI":"10.1186\/s13690-015-0080-1","article-title":"Does the Belgian diabetes type 2 care trajectory improve quality of care for diabetes patients?","volume":"73","author":"Van Casteren","journal-title":"Arch Public Health"},{"issue":"2","key":"R36","doi-asserted-by":"publisher","first-page":"18","DOI":"10.5334\/ijic.7604","article-title":"Journey through healthcare of people with complications of type 2 diabetes: a qualitative study of lived experiences","volume":"24","author":"De Baets","journal-title":"Int J Integr Care"},{"issue":"4","key":"R37","doi-asserted-by":"publisher","DOI":"10.2196\/11500","article-title":"The mHealth app usability questionnaire (MAUQ): development and validation study","volume":"7","author":"Zhou","journal-title":"JMIR Mhealth Uhealth"},{"issue":"14","key":"R38","doi-asserted-by":"publisher","first-page":"15552","DOI":"10.1002\/cam4.6202","article-title":"Evaluation of a remote monitoring app in head and neck cancer follow-up care","volume":"12","author":"van de Weerd","journal-title":"Cancer Med"},{"key":"R39","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2019.103208","article-title":"The REDCap consortium: building an international community of software platform partners","volume":"95","author":"Harris","journal-title":"J Biomed Inform"},{"key":"R40","unstructured":"Preservation - research data management. Ku Leuven. URL: https:\/\/www.kuleuven.be\/rdm\/en\/guidance\/preservation [Accessed 08-05-2024]"}],"container-title":["JMIR Research Protocols"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T21:01:01Z","timestamp":1790110861000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchprotocols.org\/2026\/1\/e93006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,22]]},"references-count":40,"URL":"https:\/\/doi.org\/10.2196\/93006","relation":{},"ISSN":["1929-0748"],"issn-type":[{"value":"1929-0748","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,22]]},"article-number":"v15i6e93006"}}